TABLE OF CONTENTS
Volume 34, Issue 1 (July (1) 2004)
Infections after Transplant |
Allografting for Older Patients |
Autografting for Sarcoma |
Autografting for Hodgkin's Disease |
Cytoprotection |
Graft-Versus-Host Disease |
Stem Cell Mobilisation |
Graft-Versus-Myeloma |
Therapy-Related Myelodysplasia |
Complications after Transplant |
Corrigendum
Review
Significance of chimerism in hematopoietic stem cell transplantation: new variations on an old theme FREE
F Khan, A Agarwal and S Agrawal
Bone Marrow Transplant 34: 1-12; advance online publication, May 24, 2004; doi:10.1038/sj.bmt.1704525
Infections after Transplant
Safety of the concomitant use of caspofungin and cyclosporin A in patients with invasive fungal infections FREE
C Sanz-Rodriguez, M Lopez-Duarte, M Jurado, J Lopez, R Arranz, J-M Cisneros, M L Martino, P J Garcia-Sanchez, P Morales, T Olivé, M Rovira and C Solano
Bone Marrow Transplant 34: 13-20; advance online publication, May 3, 2004; doi:10.1038/sj.bmt.1704516
Risk factors for late cytomegalovirus infection after allogeneic stem cell transplantation using HLA-matched sibling donor: donor lymphocyte infusion and previous history of early CMV infection FREE
D H Kim, J G Kim, N Y Lee, W J Sung, S K Sohn, J S Suh, K S Lee and K B Lee
Bone Marrow Transplant 34: 21-27; advance online publication, May 10, 2004; doi:10.1038/sj.bmt.1704528
Allografting for Older Patients
Allogeneic myeloablative transplantation for patients aged 50 years and over FREE
M Yanada, N Emi, T Naoe, H Sakamaki, T Iseki, N Hirabayashi, T Karasuno, S Chiba, Y Atsuta, N Hamajima, S Takahashi and S Kato
Bone Marrow Transplant 34: 29-35; advance online publication, May 24, 2004; doi:10.1038/sj.bmt.1704518
Autografting for Sarcoma
High-dose chemotherapy with autologous peripheral blood stem cell transplantation for bone and soft-tissue sarcomas FREE
B Kasper, T Lehnert, L Bernd, G Mechtersheimer, H Goldschmidt, A D Ho and G Egerer
Bone Marrow Transplant 34: 37-41; advance online publication, May 31, 2004; doi:10.1038/sj.bmt.1704520
Autografting for Hodgkin's Disease
Lymphocyte recovery as a positive predictor of prolonged survival after autologous peripheral blood stem cell transplantation in T-cell non-Hodgkin's lymphoma FREE
H Kim, H-J Sohn, S-E Kim, H-J Kang, S Park, S Kim, W-K Kim, J-S Lee and C Suh
Bone Marrow Transplant 34: 43-49; advance online publication, April 26, 2004; doi:10.1038/sj.bmt.1704530
Cytoprotection
A randomized trial of amifostine as a cytoprotectant for patients receiving myeloablative therapy for allogeneic hematopoietic stem cell transplantation FREE
W Y K Hwang, L-P Koh, H J Ng, P H C Tan, C T H Chuah, S C Fook, H Chow, K W Tan, C Wong, C H Tan and Y-T Goh
Bone Marrow Transplant 34: 51-56; advance online publication, June 7, 2004; doi:10.1038/sj.bmt.1704521
Graft-Versus-Host Disease
Liver graft-versus-host disease after donor lymphocyte infusion for relapses of hematologic malignancies post allogeneic hematopoietic stem cell transplantation FREE
S Y Ma, W Y Au, A K W Lie, I OL Ng, A Y H Leung, E W Tse, R H Liang, G K Lau and Y L Kwong
Bone Marrow Transplant 34: 57-61; advance online publication, May 24, 2004; doi:10.1038/sj.bmt.1704522
Transplantation outcome in allogeneic PBSCT patients according to a new chronic GVHD grading system, including extensive skin involvement, thrombocytopenia, and progressive-type onset FREE
S K Sohn, D H Kim, J G Kim, N-Y Lee, J-S Suh, K S Lee and K B Lee
Bone Marrow Transplant 34: 63-68; advance online publication, May 10, 2004; doi:10.1038/sj.bmt.1704533
Stem Cell Mobilisation
High-dose cyclophosphamide with or without etoposide for mobilization of peripheral blood progenitor cells in patients with multiple myeloma: efficacy and toxicity FREE
I Gojo, C Guo, C Sarkodee-Adoo, B Meisenberg, A Fassas, A P Rapoport, M Cottler-Fox, M Heyman, N Takebe and G Tricot
Bone Marrow Transplant 34: 69-76; advance online publication, May 10, 2004; doi:10.1038/sj.bmt.1704529
Graft-Versus-Myeloma
Graft-versus-myeloma effect following antithymocyte globulin-based reduced intensity conditioning allogeneic stem cell transplantation FREE
M Mohty, J M Boiron, G Damaj, A S Michallet, J O Bay, C Faucher, V Perreau, K Bilger, D Coso, A M Stoppa, R Tabrizi, J A Gastaut, M Michallet, D Maraninchi and D Blaise
Bone Marrow Transplant 34: 77-84; advance online publication, May 10, 2004; doi:10.1038/sj.bmt.1704531
Therapy-Related Myelodysplasia
Therapy-related myelodysplasia and leukemia occur infrequently following VP-16 priming and autotransplantation without total body irradiation FREE
E Copelan, S Hoshaw-Woodard, P Elder, S Penza, S Farag, G Marcucci, T Lin, S Ezzone, M D Scholl, T Bechtel, S Lemeshow and B Avalos
Bone Marrow Transplant 34: 85-87; advance online publication, May 24, 2004; doi:10.1038/sj.bmt.1704532
Complications after Transplant
Impact of circulating bone-resorbing cytokines on the subsequent bone loss following bone marrow transplantation FREE
W-Y Lee, K-H Baek, E-J Rhee, H-J Tae, K-W Oh, M-I Kang, K-W Lee, S-W Kim, C-C Kim and E-S Oh
Bone Marrow Transplant 34: 89-94; advance online publication, May 31, 2004; doi:10.1038/sj.bmt.1704535
